Conventus Orthopaedics, with an FDA clearance in hand, plans a gradual rollout of a new device designed to help repair shoulder fractures in a less invasive way.
Minnesota-based Rotation Medical plans in coming weeks to advance its commercial efforts for its rotator cuff system thanks to the $27.2 million in raised from new and existing investors.
The oversubscribed Series B financing included backing from new investor Life Sciences Partners who co-led funding with New Enterprise Associations. New investor Pappas Ventures also joined the round among unnamed other backers.
Cayenne Medical is $1 million away from reaching its $6 million fundraising goal, according to a regulatory filing.
Scottsdale, Ariz.-based Cayenne Medical makes medical devices used in knee and shoulder reconstruction surgeries.
Nine unnamed investors ponied up a collective $5 million in the equity and options sale, according to the filing.
Biomet said it’s completed the first U.S. implantation in an investigational device exemption trial of its Comprehensive Nano stemless shoulder device.
The stemless shoulder, which is already on the market in Europe, is based on Biomet’s T.E.S.S. stemless shoulder, which has been on the market since 2004.
In consultation with Australian health authorities, LMT Surgical issued a warning to all surgeons who implanted the company’s PyroTitan shoulder implant, advising of a reported 3% failure rate in the devices.
ArthroCare Corp. (NSDQ:ATRC) landed FDA clearance for its SpeedFix suture system for repairing tears in the shoulder joint, a common injury.
The sutures tout independent bone locking, suture tensioning and suture locking to fasten tissue to bone using double-loaded proprietary MagnumWire sutures.
The company won FDA clearance for their SpeedFix anchor system in November 2010.